Stacy P Ardoin

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. pmc Developments in the scientific understanding of lupus
    Stacy P Ardoin
    Department of Pediatrics, Duke University Medical Center, 2301 Erwin Road, Durham, NC 27710, USA
    Arthritis Res Ther 10:218. 2008
  2. ncbi request reprint The role of microparticles in inflammation and thrombosis
    S P Ardoin
    Division of Rheumatology and Immunology, Duke University Medical Center, Medical Research Service, Durham VA Hospital, Durham, NC, USA
    Scand J Immunol 66:159-65. 2007
  3. ncbi request reprint Management of dyslipidemia in children and adolescents with systemic lupus erythematosus
    S P Ardoin
    Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA
    Lupus 16:618-26. 2007
  4. ncbi request reprint Infliximab to treat chronic noninfectious uveitis in children: retrospective case series with long-term follow-up
    Stacy P Ardoin
    Division of Pediatric Rheumatology, Duke University Medical Center, Durham, NC 27710, USA
    Am J Ophthalmol 144:844-849. 2007
  5. pmc The role of cell death in the pathogenesis of autoimmune disease: HMGB1 and microparticles as intercellular mediators of inflammation
    Stacy P Ardoin
    Departments of Internal Medicine and Pediatrics, Divisions of Rheumatology and Pediatric Rheumatology, Duke University Medical Center, DUMC Box 3212, Durham, NC 27710, USA
    Mod Rheumatol 18:319-26. 2008
  6. pmc Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort
    Laura E Schanberg
    Duke University Medical Center, Durham, North Carolina 27710, USA
    Arthritis Rheum 60:1496-507. 2009
  7. ncbi request reprint The management of pediatric systemic lupus erythematosus
    Stacy P Ardoin
    Division of Pediatric Rheumatology, Duke University Medical Center, Durham, NC 27710, USA
    Nat Clin Pract Rheumatol 1:82-92. 2005
  8. doi request reprint Therapy Insight: cardiovascular disease in pediatric systemic lupus erythematosus
    Christy Sandborg
    Division of Pediatric Rheumatology, Stanford University School of Medicine, 300 Pasteur Drive, Room A085, Stanford, CA 94305, USA
    Nat Clin Pract Rheumatol 4:258-65. 2008

Detail Information

Publications8

  1. pmc Developments in the scientific understanding of lupus
    Stacy P Ardoin
    Department of Pediatrics, Duke University Medical Center, 2301 Erwin Road, Durham, NC 27710, USA
    Arthritis Res Ther 10:218. 2008
    ..Together, these findings point to new genetic and immunologic markers of disease as well as targets for new therapies...
  2. ncbi request reprint The role of microparticles in inflammation and thrombosis
    S P Ardoin
    Division of Rheumatology and Immunology, Duke University Medical Center, Medical Research Service, Durham VA Hospital, Durham, NC, USA
    Scand J Immunol 66:159-65. 2007
    ..As biomarkers, MP allow access to usually inaccessible tissues such as the endothelium. Further research will hopefully lead to interventions targeting MP release and function...
  3. ncbi request reprint Management of dyslipidemia in children and adolescents with systemic lupus erythematosus
    S P Ardoin
    Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA
    Lupus 16:618-26. 2007
    ....
  4. ncbi request reprint Infliximab to treat chronic noninfectious uveitis in children: retrospective case series with long-term follow-up
    Stacy P Ardoin
    Division of Pediatric Rheumatology, Duke University Medical Center, Durham, NC 27710, USA
    Am J Ophthalmol 144:844-849. 2007
    ..To assess a response to infliximab therapy in childhood uveitis...
  5. pmc The role of cell death in the pathogenesis of autoimmune disease: HMGB1 and microparticles as intercellular mediators of inflammation
    Stacy P Ardoin
    Departments of Internal Medicine and Pediatrics, Divisions of Rheumatology and Pediatric Rheumatology, Duke University Medical Center, DUMC Box 3212, Durham, NC 27710, USA
    Mod Rheumatol 18:319-26. 2008
    ..Given their range of activity and association with active disease, both structures may prove to be targets for effective therapy in these and other disorders...
  6. pmc Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort
    Laura E Schanberg
    Duke University Medical Center, Durham, North Carolina 27710, USA
    Arthritis Rheum 60:1496-507. 2009
    ..To evaluate risk factors for subclinical atherosclerosis in a population of patients with pediatric systemic lupus erythematosus (SLE)...
  7. ncbi request reprint The management of pediatric systemic lupus erythematosus
    Stacy P Ardoin
    Division of Pediatric Rheumatology, Duke University Medical Center, Durham, NC 27710, USA
    Nat Clin Pract Rheumatol 1:82-92. 2005
    ..Research in pediatric SLE is desperately needed and provides a unique opportunity to understand how developmental immunology and the hormonal changes associated with puberty affect the pathophysiology of SLE...
  8. doi request reprint Therapy Insight: cardiovascular disease in pediatric systemic lupus erythematosus
    Christy Sandborg
    Division of Pediatric Rheumatology, Stanford University School of Medicine, 300 Pasteur Drive, Room A085, Stanford, CA 94305, USA
    Nat Clin Pract Rheumatol 4:258-65. 2008
    ..There have been few studies of the use of statins in adults or adolescents with SLE; however, trials are currently underway to address the safety and efficacy of statin use in pediatric SLE...